Short interest in Inhibikase Therapeutics Inc (NASDAQ:IKT) increased during the last reporting period, rising from 19.43M to 19.63M. This put 21.9% of the company's publicly available shares short.

Based on the recent average volume of 632.01K shares traded per day, it would take 31.05 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.